Article
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
PloS one - 27 Aug 2009
Birjmohun Rakesh S, Vergeer Menno, Stroes Erik S G, Sandhu Manjinder S, Ricketts Sally L, Tanck Michael W, Wareham Nicholas J, Jukema J Wouter, Kastelein John J P, Khaw Kay-Tee, Boekholdt S Matthijs
Abstract excerpt
BACKGROUND: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-activity, is heavily influenced by the PON1-Q192R polymorphism. PON1 is considered to protect against atherosclerosis, but it is unclear whether this relation is independent of its carrier, HDL. In order to evaluate the atheroprotective potential of PON1, we assessed the relationships among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
